In addition, one of the more recently defined Mid-1 ubiquitination targets is non-receptor tyrosine phosphatase PTP1B, whose degradation leads to overactivation of the STAT3 signaling pathway and promotes inflammation and fibrosis in diabetic kidney disease (Chen Q. et al., 2021). This evidence concerns the gene MID1 and diabetic kidney disease.